These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10920073)

  • 1. Arrhythmogenic mechanism of an LQT-3 mutation of the human heart Na(+) channel alpha-subunit: A computational analysis.
    Wehrens XH; Abriel H; Cabo C; Benhorin J; Kass RS
    Circulation; 2000 Aug; 102(5):584-90. PubMed ID: 10920073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel LQT-3 mutation affects Na+ channel activity through interactions between alpha- and beta1-subunits.
    An RH; Wang XL; Kerem B; Benhorin J; Medina A; Goldmit M; Kass RS
    Circ Res; 1998 Jul; 83(2):141-6. PubMed ID: 9686753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pharmacology of the sodium channel mutation D1790G linked to the long-QT syndrome.
    Abriel H; Wehrens XH; Benhorin J; Kerem B; Kass RS
    Circulation; 2000 Aug; 102(8):921-5. PubMed ID: 10952963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel arrhythmogenic mechanism revealed by a long-QT syndrome mutation in the cardiac Na(+) channel.
    Abriel H; Cabo C; Wehrens XH; Rivolta I; Motoike HK; Memmi M; Napolitano C; Priori SG; Kass RS
    Circ Res; 2001 Apr; 88(7):740-5. PubMed ID: 11304498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of human cardiac Na+ channel mutations in the congenital long QT syndrome.
    Wang DW; Yazawa K; George AL; Bennett PB
    Proc Natl Acad Sci U S A; 1996 Nov; 93(23):13200-5. PubMed ID: 8917568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel LQT-3 mutation disrupts an inactivation gate complex with distinct rate-dependent phenotypic consequences.
    Bankston JR; Sampson KJ; Kateriya S; Glaaser IW; Malito DL; Chung WK; Kass RS
    Channels (Austin); 2007; 1(4):273-80. PubMed ID: 18708744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into the molecular mechanisms of bradycardia-triggered arrhythmias in long QT-3 syndrome.
    Clancy CE; Tateyama M; Kass RS
    J Clin Invest; 2002 Nov; 110(9):1251-62. PubMed ID: 12417563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-QT syndrome-related sodium channel mutations probed by the dynamic action potential clamp technique.
    Berecki G; Zegers JG; Bhuiyan ZA; Verkerk AO; Wilders R; van Ginneken AC
    J Physiol; 2006 Jan; 570(Pt 2):237-50. PubMed ID: 16254012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rate-dependent QT shortening mechanism for the LQT3 deltaKPQ mutant.
    Nagatomo T; January CT; Ye B; Abe H; Nakashima Y; Makielski JC
    Cardiovasc Res; 2002 Jun; 54(3):624-9. PubMed ID: 12031708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inherited Brugada and long QT-3 syndrome mutations of a single residue of the cardiac sodium channel confer distinct channel and clinical phenotypes.
    Rivolta I; Abriel H; Tateyama M; Liu H; Memmi M; Vardas P; Napolitano C; Priori SG; Kass RS
    J Biol Chem; 2001 Aug; 276(33):30623-30. PubMed ID: 11410597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arrhythmogenic consequences of Na+ channel mutations in the transmurally heterogeneous mammalian left ventricle: analysis of the I1768V SCN5A mutation.
    Flaim SN; Giles WR; McCulloch AD
    Heart Rhythm; 2007 Jun; 4(6):768-78. PubMed ID: 17556201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel mutation L619F in the cardiac Na+ channel SCN5A associated with long-QT syndrome (LQT3): a role for the I-II linker in inactivation gating.
    Wehrens XH; Rossenbacker T; Jongbloed RJ; Gewillig M; Heidbüchel H; Doevendans PA; Vos MA; Wellens HJ; Kass RS
    Hum Mutat; 2003 May; 21(5):552. PubMed ID: 12673799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential calcium sensitivity in Na
    Abdelsayed M; Baruteau AE; Gibbs K; Sanatani S; Krahn AD; Probst V; Ruben PC
    J Physiol; 2017 Sep; 595(18):6165-6186. PubMed ID: 28734073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biophysical phenotypes of SCN5A mutations causing long QT and Brugada syndromes.
    Baroudi G; Chahine M
    FEBS Lett; 2000 Dec; 487(2):224-8. PubMed ID: 11150514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel SCN5A mutation associated with long QT-3: altered inactivation kinetics and channel dysfunction.
    Rivolta I; Clancy CE; Tateyama M; Liu H; Priori SG; Kass RS
    Physiol Genomics; 2002 Sep; 10(3):191-7. PubMed ID: 12209021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gating-dependent mechanisms for flecainide action in SCN5A-linked arrhythmia syndromes.
    Viswanathan PC; Bezzina CR; George AL; Roden DM; Wilde AA; Balser JR
    Circulation; 2001 Sep; 104(10):1200-5. PubMed ID: 11535580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel and lethal de novo LQT-3 mutation in a newborn with distinct molecular pharmacology and therapeutic response.
    Bankston JR; Yue M; Chung W; Spyres M; Pass RH; Silver E; Sampson KJ; Kass RS
    PLoS One; 2007 Dec; 2(12):e1258. PubMed ID: 18060054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis of ranolazine block of LQT-3 mutant sodium channels: evidence for site of action.
    Fredj S; Sampson KJ; Liu H; Kass RS
    Br J Pharmacol; 2006 May; 148(1):16-24. PubMed ID: 16520744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired stretch modulation in potentially lethal cardiac sodium channel mutants.
    Banderali U; Juranka PF; Clark RB; Giles WR; Morris CE
    Channels (Austin); 2010; 4(1):12-21. PubMed ID: 20090423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Channel openings are necessary but not sufficient for use-dependent block of cardiac Na(+) channels by flecainide: evidence from the analysis of disease-linked mutations.
    Liu H; Tateyama M; Clancy CE; Abriel H; Kass RS
    J Gen Physiol; 2002 Jul; 120(1):39-51. PubMed ID: 12084774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.